2023 MIPS Allergy/Immunology Specialty Quality Measures Set
CMS removed two popular quality measures from traditional MIPS – and from the allergy/immunology quality specialty measures set – in 2023.
CMS extends MIPS hardship exemption in 2023
CMS announced physicians and group practices can apply for a 2023 MIPS Extreme and Uncontrollable Circumstances (EUC) hardship exception.
2023 Prior Authorization Reforms
CMS released a final rule that addresses changes to the prior authorization process under Medicare Advantage.
The Advocacy Council works for you
We’ve worked independently and with like-minded medical coalitions on important issues that affect allergy practices.
2023 Recommendations to address health care workforce challenges
Three months into the 118th Congress, we are beginning to get a sense of which issues Congress and its committees will prioritize.
2023 MedPAC report encourages physician payment reform
These reports make nonbinding recommendations to Congress and also assess various aspects of Medicare payment policy.
2023 HIPAA Update
HIPAA violations have been more common in recent years and create potential financial liabilities for breach of confidentiality of PHI.
AMA Medicare specialty impact analysis
A/I was one of 16 specialty groups to experience a 2% cut in Medicare payments as a result of the 2023 Medicare PFS final rule and the CAA.
2023 Call for State Delegates
Our HOD's success depends on representation across the country. We’re looking for active College members, like you, to serve!
J. Allen Meadows receives the 2023 AMPAC Award
Dr. Meadows has been influential in the ACAAI’s Allergy Strike Force – bringing College members and leadership to Washington, DC annually.
2023 Prior Authorization Initiatives
Policymakers are starting to take notice of how prior authorization requirements are worsening the administrative burden on providers and ultimately impacting …
2023 – Ending the Public Health Emergency
The document provides a high-level overview of anticipated ways the end of the PHE will impact direct supervision under Medicare, Medicare telehealth services,…
2023 MIPS Audits
CMS announced that, starting in January 2023, it would begin auditing clinicians for the Merit-Based Incentive Payment System (MIPS) 2019, 2020, and 2021 perfo…
Advocating for allergists locally
The HOD is positioned to effect change by identifying and addressing legislative and policy issues before they can adversely affect our specialty.
2023 – Food Allergy Legislation Introduced
In order to protect children with food allergies, the proposed legislation will require all School Breakfast Program and National Lunch Program school food ser…
2023 RTM services are now under general supervision
Effective Jan. 1, any Remote Therapeutic Monitoring (RTM) services (CPT codes 98975, 98976, 98977, 98980, and 98981) may be provided under general, rather than…
2022 HOD Summary and 2023 Plans
Learn more about the delegate job description and responsibilities. Applications will be accepted through Feb. 28 for state delegates.
Standardizing claim attachments
The Department of Health and Human Services (HHS) announced a long-awaited proposed rule for new data standards for health care attachments and electronic sign…
Affect how policies and laws impact our specialty
The House of Delegates represents the interests of allergists to policymakers, and we need you to be an advocate at the local and state level.
NSA GFE and AEBP – Portions delayed
CMS announced in guidance that it will continue to delay enforcing the convening/co-provider good faith estimate requirement of the No Surprises Act, as well a…